Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Betahistine Dihydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 126Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Altamira Announces Patent Office Decision to Grant for Intranasal Betahistine
    Altamira Announces Patent Office Decision to Grant for Intranasal Betahistine

    10 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/10/2778332/0/en/Altamira-Therapeutics-Announces-European-Patent-Office-Decision-to-Grant-for-Patent-Application-Covering-Intranasal-Betahistine.html

    GLOBENEWSWIRE
    10 Nov 2023
    Share Share
    Altamira Therapeutics Reports Positive Conclusions from Independent Meta-Analysis of Clinical Studies with Betahistine
    Altamira Therapeutics Reports Positive Conclusions from Independent Meta-Analysis of Clinical Studies with Betahistine

    10 Apr 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=748222&lang=en

    ACCESSWIRE
    10 Apr 2023
    Share Share
    Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial
    Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial

    03 Jul 2019

    // GLOBE NEWSWIRE

    http://www.globenewswire.com/news-release/2019/07/03/1877879/0/en/Auris-Medical-Completes-Enrollment-of-Phase-1b-Proof-Of-Concept-Trial-of-AM-201-in-Antipsychotic-Induced-Weight-Gain.html

    GLOBE NEWSWIRE
    03 Jul 2019
    Share Share
    EMA recommends suspension of medicines due to unreliable studies from Micro Therapeutic Research Labs
    EMA recommends suspension of medicines due to unreliable studies from Micro Therapeutic Research Labs

    23 Aug 2017

    // EMA

    https://www.pharmacompass.com/pdf/news/ema-recommends-suspension-of-medicines-due-to-unreliable-studies-from-micro-therapeutic-research-labs-1503552764.pdf

    EMA
    23 Aug 2017
    Share Share
    Pharmascience Inc. recalls Betahistine due to Labelling error
    Pharmascience Inc. recalls Betahistine due to Labelling error

    12 May 2016

    // HEALTH CANADA

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58558r-eng.php

    HEALTH CANADA
    12 May 2016
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    02 May 2015

    // Eric Palmer FIERCE PHARMA MFG

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share